data_2jp3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jp3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 4' ' ' VAL . . . -170.76 68.87 0.14 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -52.48 -9.54 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.674 2.249 . . . . 0.0 111.978 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' A' ' 6' ' ' LYS . 24.2 t -76.9 -32.46 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.666 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 7' ' ' GLY . 4.0 t0 75.76 -35.03 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.531 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 4' ' ' VAL . 32.1 tttt -68.1 7.06 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.588 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 5' ' ' ASP . . . -85.97 -46.91 5.21 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.16 162.39 21.55 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.503 ' O ' ' CD2' ' A' ' 12' ' ' TYR . 29.4 Cg_endo -66.5 -14.74 45.32 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.277 1.985 . . . . 0.0 112.015 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.499 ' CD2' ' O ' ' A' ' 10' ' ' PHE . 52.4 t80 -66.3 3.51 0.9 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.339 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.517 ' C ' ' H ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -75.47 -33.97 60.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.503 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.503 ' CD2' ' O ' ' A' ' 9' ' ' PRO . 15.2 m-85 -60.12 -2.05 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.397 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 11' ' ' TYR . 29.7 t70 -78.79 9.4 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.399 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.521 ' CD1' ' N ' ' A' ' 15' ' ' GLU . 1.0 OUTLIER -72.18 -24.14 61.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.695 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.521 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 0.1 OUTLIER -40.55 -23.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.669 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' TRP . 19.9 m -62.88 -38.24 90.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.536 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.424 ' C ' ' CD2' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -55.75 -19.0 9.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -88.19 -70.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.794 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 mt -52.03 -41.67 62.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.58 -28.84 62.6 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.08 -43.43 88.42 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mt -62.57 -40.08 95.73 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -71.6 -35.53 56.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.654 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -47.17 -47.97 23.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.717 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.41 -45.14 96.54 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.1 -34.51 90.16 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 32.6 tp -71.54 -49.7 38.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.416 ' C ' ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -49.21 -45.61 44.59 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.456 ' O ' ' N ' ' A' ' 32' ' ' GLY . 0.8 OUTLIER -56.39 -54.86 40.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.812 179.001 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.56 -28.54 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.66 -29.57 36.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.844 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -67.34 -53.21 26.56 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.5 tt -59.11 -39.97 79.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 0.0 110.156 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -51.0 -53.51 32.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.416 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.82 -38.2 69.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.153 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -59.61 -41.88 91.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.395 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.456 ' C ' ' H ' ' A' ' 39' ' ' GLY . 0.9 OUTLIER -47.01 -40.26 14.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.504 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 p -66.67 1.49 1.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.339 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 36' ' ' ALA . . . -134.26 8.54 4.72 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -90.98 -40.18 11.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.445 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 5.5 p -53.74 -37.5 63.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.52 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.52 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 9.5 ptmm? -77.72 -42.09 35.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.719 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.56 -15.5 62.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -75.99 -33.77 59.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.58 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.18 -21.47 13.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.359 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.602 ' N ' HD21 ' A' ' 46' ' ' ASN . 0.5 OUTLIER -104.25 -44.0 5.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.537 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.522 ' CD2' ' O ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER 42.76 -172.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.991 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.53 152.81 39.44 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.311 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.92 18.63 0.73 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.257 1.971 . . . . 0.0 112.549 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 m -142.96 -46.65 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.436 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.34 -30.5 71.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.845 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.523 ' C ' ' H ' ' A' ' 54' ' ' GLU . 3.0 tm? -83.31 -53.24 0.59 Allowed Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.366 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.1 7.38 0.11 Allowed 'Trans proline' 0 N--CA 1.5 1.886 0 CA-C-N 121.212 1.469 . . . . 0.0 112.745 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.523 ' H ' ' C ' ' A' ' 52' ' ' LEU . 67.7 tt0 -76.69 -40.74 47.86 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.651 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.544 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -86.26 -9.79 55.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.296 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.05 3.78 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.467 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.568 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -71.72 -43.71 11.59 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.966 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 57' ' ' THR . 23.4 Cg_exo -60.64 -31.18 91.83 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.459 2.106 . . . . 0.0 111.924 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 tt -88.43 -22.94 23.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.657 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.9 mt -96.42 -26.53 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.548 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -142.24 157.46 63.23 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.246 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -37.65 -65.16 0.16 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.426 2.084 . . . . 0.0 112.207 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.54 8.45 77.23 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.4 m -101.53 144.3 30.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 110.555 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.98 -18.37 61.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.58 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.418 ' O ' ' OG1' ' A' ' 67' ' ' THR . 0.3 OUTLIER -137.76 -163.27 1.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.574 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 66' ' ' SER . 48.7 p . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.549 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -170.76 68.87 0.14 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -52.48 -9.54 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.674 2.249 . . . . 0.0 111.978 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 6' ' ' LYS . 24.2 t -76.9 -32.46 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.666 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 7' ' ' GLY . 4.0 t0 75.76 -35.03 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.531 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.738 ' H ' HG12 ' A' ' 4' ' ' VAL . 32.1 tttt -68.1 7.06 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.588 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 5' ' ' ASP . . . -85.97 -46.91 5.21 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.16 162.39 21.55 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.503 ' O ' ' CD2' ' A' ' 12' ' ' TYR . 29.4 Cg_endo -66.5 -14.74 45.32 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.277 1.985 . . . . 0.0 112.015 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.499 ' O ' ' CD2' ' A' ' 10' ' ' PHE . 52.4 t80 -66.3 3.51 0.9 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.339 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -75.47 -33.97 60.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.503 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.503 ' CD2' ' O ' ' A' ' 9' ' ' PRO . 15.2 m-85 -60.12 -2.05 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.397 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 11' ' ' TYR . 29.7 t70 -78.79 9.4 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.399 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.521 ' CD1' ' N ' ' A' ' 15' ' ' GLU . 1.0 OUTLIER -72.18 -24.14 61.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.695 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.521 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 0.1 OUTLIER -40.55 -23.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.669 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' TRP . 19.9 m -62.88 -38.24 90.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.536 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -55.75 -19.0 9.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.542 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.692 ' N ' HD23 ' A' ' 17' ' ' LEU . 28.6 tt0 -88.19 -70.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.794 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 mt -52.03 -41.67 62.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.58 -28.84 62.6 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.08 -43.43 88.42 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mt -62.57 -40.08 95.73 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.5 mp -71.6 -35.53 56.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.654 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -47.17 -47.97 23.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.717 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.41 -45.14 96.54 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.1 -34.51 90.16 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 32.6 tp -71.54 -49.7 38.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.785 ' O ' HD12 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -49.21 -45.61 44.59 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.456 ' O ' ' N ' ' A' ' 32' ' ' GLY . 0.8 OUTLIER -56.39 -54.86 40.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.812 179.001 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.56 -28.54 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 28' ' ' LEU . . . -80.66 -29.57 36.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.844 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -67.34 -53.21 26.56 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.446 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 8.5 tt -59.11 -39.97 79.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 0.0 110.156 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.433 ' N ' HG23 ' A' ' 33' ' ' ILE . . . -51.0 -53.51 32.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.416 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.54 ' O ' HD23 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -55.82 -38.2 69.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.153 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -59.61 -41.88 91.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.395 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.567 ' O ' HD23 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -47.01 -40.26 14.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.504 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 p -66.67 1.49 1.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.339 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 36' ' ' ALA . . . -134.26 8.54 4.72 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -90.98 -40.18 11.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.445 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 5.5 p -53.74 -37.5 63.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.52 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -77.72 -42.09 35.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.719 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.41 ' HA ' ' H ' ' A' ' 47' ' ' HIS . 0.5 OUTLIER -65.56 -15.5 62.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -75.99 -33.77 59.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.58 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.18 -21.47 13.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.359 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.491 ' C ' ' CG ' ' A' ' 47' ' ' HIS . 2.5 m120 -104.25 -44.0 5.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.537 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.491 ' CG ' ' C ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER 42.76 -172.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.991 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.53 152.81 39.44 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.311 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.92 18.63 0.73 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.257 1.971 . . . . 0.0 112.549 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 m -142.96 -46.65 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.436 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.34 -30.5 71.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.845 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.714 HD13 ' C ' ' A' ' 52' ' ' LEU . 3.0 tm? -83.31 -53.24 0.59 Allowed Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.366 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.1 7.38 0.11 Allowed 'Trans proline' 0 N--CA 1.5 1.886 0 CA-C-N 121.212 1.469 . . . . 0.0 112.745 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' A' ' 52' ' ' LEU . 67.7 tt0 -76.69 -40.74 47.86 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.651 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.592 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -86.26 -9.79 55.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.296 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.05 3.78 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.467 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.568 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -71.72 -43.71 11.59 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.966 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 57' ' ' THR . 23.4 Cg_exo -60.64 -31.18 91.83 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.459 2.106 . . . . 0.0 111.924 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 tt -88.43 -22.94 23.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.657 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.9 mt -96.42 -26.53 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.548 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -142.24 157.46 63.23 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.246 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -37.65 -65.16 0.16 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.426 2.084 . . . . 0.0 112.207 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.54 8.45 77.23 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.4 m -101.53 144.3 30.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 110.555 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.98 -18.37 61.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.58 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.76 -163.27 1.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.574 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.7 p . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.549 179.976 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -170.76 68.87 0.14 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -52.48 -9.54 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.674 2.249 . . . . 0.0 111.978 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 6' ' ' LYS . 24.2 t -76.9 -32.46 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.666 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 7' ' ' GLY . 4.0 t0 75.76 -35.03 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.531 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.738 ' H ' HG12 ' A' ' 4' ' ' VAL . 32.1 tttt -68.1 7.06 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.588 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 5' ' ' ASP . . . -85.97 -46.91 5.21 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.16 162.39 21.55 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.503 ' O ' ' CD2' ' A' ' 12' ' ' TYR . 29.4 Cg_endo -66.5 -14.74 45.32 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.277 1.985 . . . . 0.0 112.015 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.499 ' O ' ' CD2' ' A' ' 10' ' ' PHE . 52.4 t80 -66.3 3.51 0.9 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.339 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -75.47 -33.97 60.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.503 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.503 ' CD2' ' O ' ' A' ' 9' ' ' PRO . 15.2 m-85 -60.12 -2.05 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.397 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 11' ' ' TYR . 29.7 t70 -78.79 9.4 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.399 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.521 ' CD1' ' N ' ' A' ' 15' ' ' GLU . 1.0 OUTLIER -72.18 -24.14 61.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.695 -179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.521 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 0.1 OUTLIER -40.55 -23.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.669 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' TRP . 19.9 m -62.88 -38.24 90.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.536 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -55.75 -19.0 9.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.692 ' N ' HD23 ' A' ' 17' ' ' LEU . 28.6 tt0 -88.19 -70.88 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.794 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 mt -52.03 -41.67 62.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.58 -28.84 62.6 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.08 -43.43 88.42 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mt -62.57 -40.08 95.73 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 23' ' ' ILE . 1.5 mp -71.6 -35.53 56.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.654 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -47.17 -47.97 23.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.717 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.41 -45.14 96.54 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.1 -34.51 90.16 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 32.6 tp -71.54 -49.7 38.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.785 ' O ' HD12 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -49.21 -45.61 44.59 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.456 ' O ' ' N ' ' A' ' 32' ' ' GLY . 0.8 OUTLIER -56.39 -54.86 40.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.812 179.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.56 -28.54 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 28' ' ' LEU . . . -80.66 -29.57 36.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.844 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 29' ' ' CYS . . . -67.34 -53.21 26.56 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.446 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 8.5 tt -59.11 -39.97 79.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 0.0 110.156 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.433 ' N ' HG23 ' A' ' 33' ' ' ILE . . . -51.0 -53.51 32.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.416 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.54 ' O ' HD23 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -55.82 -38.2 69.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.153 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -59.61 -41.88 91.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.395 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.567 ' O ' HD23 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -47.01 -40.26 14.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.504 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 p -66.67 1.49 1.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.339 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 36' ' ' ALA . . . -134.26 8.54 4.72 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -90.98 -40.18 11.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.445 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 5.5 p -53.74 -37.5 63.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.52 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.52 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 9.5 ptmm? -77.72 -42.09 35.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.719 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.41 ' HA ' ' H ' ' A' ' 47' ' ' HIS . 0.5 OUTLIER -65.56 -15.5 62.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -75.99 -33.77 59.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.58 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.18 -21.47 13.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.359 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.617 HD22 ' N ' ' A' ' 46' ' ' ASN . 0.5 OUTLIER -104.25 -44.0 5.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.537 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.522 ' CD2' ' O ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER 42.76 -172.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.991 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.53 152.81 39.44 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.311 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.92 18.63 0.73 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.257 1.971 . . . . 0.0 112.549 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 m -142.96 -46.65 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.436 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.34 -30.5 71.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.845 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.714 HD13 ' C ' ' A' ' 52' ' ' LEU . 3.0 tm? -83.31 -53.24 0.59 Allowed Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.366 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.1 7.38 0.11 Allowed 'Trans proline' 0 N--CA 1.5 1.886 0 CA-C-N 121.212 1.469 . . . . 0.0 112.745 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' A' ' 52' ' ' LEU . 67.7 tt0 -76.69 -40.74 47.86 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.651 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.592 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -86.26 -9.79 55.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.296 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.05 3.78 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.467 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.568 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -71.72 -43.71 11.59 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.966 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 57' ' ' THR . 23.4 Cg_exo -60.64 -31.18 91.83 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.459 2.106 . . . . 0.0 111.924 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 tt -88.43 -22.94 23.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.657 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.9 mt -96.42 -26.53 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.548 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -142.24 157.46 63.23 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.246 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -37.65 -65.16 0.16 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.426 2.084 . . . . 0.0 112.207 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.54 8.45 77.23 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.4 m -101.53 144.3 30.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 110.555 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.98 -18.37 61.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.58 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.76 -163.27 1.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.574 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.7 p . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.549 179.976 . . . . . . . . 0 0 . 1 stop_ save_